Bjorklund v. Novo Nordisk A/S et al
| Jaclyn Bjorklund |
| Novo Nordisk A/S, Novo Nordisk North America Operations A/S, Novo Nordisk US Holdings Inc., Novo Nordisk US Commercial Holdings Inc., Novo Nordisk Inc., Novo Nordisk Research Center Seattle, Inc., Novo Nordisk Pharmaceutical Industries LP, Eli Lilly and Company, Novo Nordisk U S Holdings Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk Inc, Novo Nordisk Research Center Seattle Inc, Novo Nordisk Pharmaceutical Industries L P and Eli Lilly & Co |
| 2:2023cv01020 |
| August 2, 2023 |
| US District Court for the Western District of Louisiana |
| James D Cain |
| Kathleen Kay |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 Diversity-Personal Injury |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 18, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 27 DIVERSITY JURISDICTION DISCLOSURE STATEMENT by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (aty,Surprenant, Diana) |
| Filing 26 CORPORATE DISCLOSURE STATEMENT by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc identifying Corporate Parent Novo Nordisk A S for Novo Nordisk U S Holdings Inc; Corporate Parent Novo Nordisk U S Research Investment Holdings Inc for Novo Nordisk Research Center Seattle Inc; Corporate Parent Novo Nordisk U S Holdings Inc for Novo Nordisk U S Commercial Holdings Inc; Corporate Parent Novo Nordisk U S Manufacturing Holdings Inc for Novo Nordisk Pharmaceutical Industries L P; Corporate Parent Novo Nordisk U S Commercial Holdings Inc for Novo Nordisk Inc. (aty,Surprenant, Diana) |
| Filing 25 DIVERSITY JURISDICTION DISCLOSURE STATEMENT by Eli Lilly & Co. (aty,Ieyoub, Christopher) |
| Filing 24 CORPORATE DISCLOSURE STATEMENT by Eli Lilly & Co. (aty,Ieyoub, Christopher) |
Filing 23
ELECTRONIC ORDER granting #13 Motion for Extension of Time to Answer #1 Complaint and #5 Amended Complaint. Eli Lilly & Co answer due 10/16/2023. Defendant's request that "that an extension be granted of any related briefing deadlines such that Plaintiffs opposition to any responsive motion is due November 8, 2023, and Lillys reply brief is due November 17, 2023" is denied. Deadlines for responses to any other filings will be fixed at time of filing. Signed by Magistrate Judge Kathleen Kay on 9/26/2023. (jud,Kay, Kathleen) Modified on 9/26/2023 to edit text (Jones, P).
|
| Filing 22 MOTION for Loren H. Brown to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5699910) by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 9/21/2023. (Attachments: #1 Certificate of good standing 1 Certificate of Good Standing for Loren Brown, #2 Proposed order)(aty,Surprenant, Diana) |
| Filing 21 MOTION for Jonathan M. Sedgh to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5699551) by Jaclyn Bjorklund. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 9/21/2023. (Attachments: #1 Certificate of good standing, #2 Proposed order)(aty,Rocha, Rene) |
| Filing 20 MOTION for T. Michael Morgan to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5696452) by All Plaintiffs. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 9/19/2023. (Attachments: #1 Certificate of good standing, #2 Proposed order)(aty,Rocha, Rene) |
| Filing 19 MOTION for Josh Autry to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5695931) by Jaclyn Bjorklund. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 9/19/2023. (Attachments: #1 Certificate of good standing, #2 Proposed order)(aty,Rocha, Rene) |
| Filing 18 NOTICE of Diversity Jurisdiction Disclosure Statement Requirement re: #14 Motion for Extension of Time to File Answer sent to Diana Cole Surprenant on behalf of Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Diversity Jurisdiction Disclosure Statement due by 9/28/2023. (crt,Crick, S) |
| Filing 17 NOTICE of Corporate Disclosure Statement Requirement re: #14 Motion for Extension of Time to File Answer sent to Diana Cole Surprenant on behalf of Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Corporate Disclosure Statement due by 9/28/2023. (crt,Crick, S) |
| Filing 16 NOTICE of Diversity Jurisdiction Disclosure Statement Requirement re: #13 Motion for Extension of Time to File Answer sent to Christopher P Ieyoub on behalf of Eli Lilly & Co. Diversity Jurisdiction Disclosure Statement due by 9/28/2023. (crt,Crick, S) |
| Filing 15 NOTICE of Corporate Disclosure Statement Requirement re: #13 Motion for Extension of Time to File Answer sent to Christopher P Ieyoub on behalf of Eli Lilly & Co. Corporate Disclosure Statement due by 9/28/2023. (crt,Crick, S) |
| Filing 14 Consent MOTION for Extension of Time to File Answer re #5 Amended Complaint, with consent by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 9/14/2023. (Attachments: #1 Proposed order)(Attorney Diana Cole Surprenant added to party Novo Nordisk Inc(pty:dft), Attorney Diana Cole Surprenant added to party Novo Nordisk Pharmaceutical Industries L P(pty:dft), Attorney Diana Cole Surprenant added to party Novo Nordisk Research Center Seattle Inc(pty:dft), Attorney Diana Cole Surprenant added to party Novo Nordisk U S Commercial Holdings Inc(pty:dft), Attorney Diana Cole Surprenant added to party Novo Nordisk U S Holdings Inc(pty:dft))(aty,Surprenant, Diana) |
| Filing 13 MOTION for Extension of Time to File Answer re #1 Complaint,, #5 Amended Complaint, with consent by Eli Lilly & Co. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 9/13/2023. (Attachments: #1 Proposed order)(Attorney Christopher P Ieyoub added to party Eli Lilly & Co(pty:dft))(aty,Ieyoub, Christopher) |
| Filing 12 AFFIDAVIT of Service for Summons with First Amended Complaint served on Novo Nordisk US Holdings, Inc. on 8/28/2023, filed by Jaclyn Bjorklund. (aty,Rocha, Rene) |
| Filing 11 AFFIDAVIT of Service for Summons with First Amended Complaint served on Novo Nordisk US Commercial Holdings, Inc. on 8/28/2023, filed by Jaclyn Bjorklund. (aty,Rocha, Rene) |
| Filing 10 AFFIDAVIT of Service for Summons with First Amended Complaint served on Novo Nordisk Research Center Seattle, Inc. on 8/28/2023, filed by Jaclyn Bjorklund. (aty,Rocha, Rene) |
| Filing 9 AFFIDAVIT of Service for Summons with First Amended Complaint served on Novo Nordisk Pharmaceutical Industries, LP on 8/28/2023, filed by Jaclyn Bjorklund. (aty,Rocha, Rene) |
| Filing 8 AFFIDAVIT of Service for Summons with First Amended Complaint served on Novo Nordisk Inc. on 8/28/2023, filed by Jaclyn Bjorklund. (aty,Rocha, Rene) |
| Filing 7 AFFIDAVIT of Service for Summons with First Amended Complaint served on Eli Lilly & Co. on 8/25/2023, filed by Jaclyn Bjorklund. (aty,Rocha, Rene) |
| SUMMONS Returned Executed by Jaclyn Bjorklund. Eli Lilly & Co served on 8/25/2023, answer due 9/15/2023; Novo Nordisk Inc served on 8/28/2023, answer due 9/18/2023; Novo Nordisk Pharmaceutical Industries L P served on 8/28/2023, answer due 9/18/2023; Novo Nordisk Research Center Seattle Inc served on 8/28/2023, answer due 9/18/2023; Novo Nordisk U S Commercial Holdings Inc served on 8/28/2023, answer due 9/18/2023; Novo Nordisk U S Holdings Inc served on 8/28/2023, answer due 9/18/2023. ADMINISTRATIVE ENTRY as documents electronically filed in error as #7 , #8 , #9 , #10 , #11 & #12 Affidavits of Service. (crt,Crick, S) |
| Filing 6 SUMMONS ISSUED as to Eli Lilly & Co, Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (crt,Crick, S) |
| Filing 5 AMENDED COMPLAINT against Eli Lilly & Co, Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc with Jury Demand filed by Jaclyn Bjorklund.(aty,Rocha, Rene) |
| Filing 4 DIVERSITY JURISDICTION DISCLOSURE STATEMENT by Jaclyn Bjorklund. (aty,Rocha, Rene) |
| Filing 3 NOTICE of Diversity Jurisdiction Disclosure Statement Requirement re: #1 Complaint sent to Rene Fernandez Rocha on behalf of Jaclyn Bjorklund. Diversity Jurisdiction Disclosure Statement due by 8/17/2023. (crt,Crick, S) |
| Filing 2 SUMMONS ISSUED as to Eli Lilly & Co, Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (crt,Crick, S) |
| Filing 1 COMPLAINT against Eli Lilly and Company, Novo Nordisk A/S, Novo Nordisk Inc., Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries LP, Novo Nordisk Research Center Seattle, Inc., Novo Nordisk US Commercial Holdings Inc., Novo Nordisk US Holdings Inc. with Jury Demand (Filing fee $402, receipt number ALAWDC-5641648) filed by Jaclyn Bjorklund. (Attachments: #1 Civil cover sheet)(Attorney Rene Fernandez Rocha added to party Jaclyn Bjorklund(pty:pla))(aty,Rocha, Rene) |
| CASE Assigned to Judge James D Cain, Jr and Magistrate Judge Kathleen Kay. (crt,Crick, S) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Louisiana Western District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
